Financials

News Ideas Technicals

4186 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TAIWAN ADVANCE BIO-PHARM INC operating, investing, and financing activities

4186 free cash flow for H2 23 is 28.88 M TWD. For 2023, 4186 free cash flow was -1.13 M TWD and operating cash flow was 10.81 M TWD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—